Denali Corp (DNLI): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
Denali Therapeutics (DNLI) qon-miya to'sig'ini kesib o'tuvchi dori yetkazib berish usulidan foydalangan holda Altsgeymer va Parkinson kasalliklari uchun davolash vositalarini ishlab chiqadi. Bu istiqbolli klinik bosqichdagi loyihalar portfelining rivojlanishini qo'llab-quvvatlaydi, bu esa kompaniyaning o'sish sur'atlariga nisbatan baholangan qiymatini tasdiqlaydi, bunda parametr belgisi 0.00 ga tengdir. Biroq, neyroxirurgiyaning murakkabligi va tashqi kapitalga bog'liqlik sezilarli xatarlarni yuzaga keltiradi.
Denali Therapeutics (DNLI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Denali Therapeutics|DNLI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati denalitherapeutics.com|DNLI - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Denali Therapeutics Inc|DNLI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Denali Therapeutics|Shoshilinch likvidlik denalitherapeutics.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
DNLI - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Denali Therapeutics|DNLI - P/E multiplikatori|Forvard P/E multiplikatori Denali Corp|DNLI - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Denali Therapeutics Inc|DNLI - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Denali Therapeutics|DNLI - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi denalitherapeutics.com|DNLI - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Denali Therapeutics
Kompaniyaning jamlanma tahliliyoti:Denali
Denali Therapeutics (DNLI) hamkorlik to'lovlarining beqarorligiga bog'liq bo'lgan biotexnologiya sektori uchun foyda o'sish sur'atlariga asoslangan baholash barqarorlikning muhim filtri hisoblanadi. Ushbu grafikda PEG ko'paytirgichi bilan ifodalangan o'sish sur'atlariga nisbatan P/E koeffitsiyenti investor neyrodegeneratsiya terapiyasidagi kelajakdagi muvaffaqiyatlar uchun haddan tashqari ko'p to'layotganini yoki yo'qligini belgilaydi; birdan past qiymat aktivning kengayish salohiyatiga nisbatan past baholanganligidan dalolat beradi.
Raqobatdosh kompaniyalar
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|RGC: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Axsome Therapeutics - PEG multiplikatori|ACAD - PEG multiplikatori|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|VKTX (Viking Therapeutics Inc) - Narxning foydaga va o‘sish sur’atiga nisbati|SUPN (Supernus Pharma) - PEG multiplikatori|Catalyst Corp (CPRX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori HRMY (Harmony Biosciences)|BHVN (biohavenpharma.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Amylyx Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati TRVI (Trevi Therapeutics Inc)|Praxis Medicines - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CBLL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Prothena (PRTA)|Narxning foydaga va o‘sish sur’atiga nisbati Alector Inc.|ANNX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori OMER|PEG multiplikatori Neurogene Therapeutics (NGNE)|Narxning foydaga va o‘sish sur’atiga nisbati AC Immune ACIU|VYGR (voyagertherapeutics.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Neumora Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scilex Holding|TVGN (Tevogen Bio Holdings, Inc.) - Narx-foyda va o‘sish multiplikatori|Alpha Cognition Inc. (ACOG) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CGTX|IKT (inhibikase.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori SAVA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati assertiotx.com|PEG multiplikatori COYA (Coya Therapeutics)|VTGN - Narx-foyda va o‘sish multiplikatori|OVID - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acumenpharm.com ABOS|CRVO: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ATHE|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PEPG (PepGen Corp)|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (relmada.com)|PEG multiplikatori ANVS (Annovis Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Therapeutics Inc (GRCE)|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NRSN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narx-foyda va o‘sish multiplikatori MTVA|PEG multiplikatori NeurAxis Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|PASG (passagebio.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|Athira Pharma - PEG multiplikatori|ADXN (Addex Therapeutics Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ALZN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Cyclerion Therapeutics, Inc. (CYCN)|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KTTA (Pasithea)|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Cara Therapeutics Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Eliem Therapeutics ELYM|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|Longboard Pharmaceuticals Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori MRNS|NKGN (NKGen Biotech Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori NRBO|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SNPX (Synaptogenix)|Trevena Inc. (TRVN) - O‘sish sur’atiga tuzatilgan narx-foyda|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical Inc.)|CERE: PEG multiplikatori
